Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Qingshan Li
Observed names:
Qing-Shan Li,
Qingshan Li
Institution:
Affiliated Hospital of Chengde Medical College
Observed institutions:
Jinan University,
Chengde Medical University,
Jilin University,
Affiliated Hospital of Chengde Medical College,
Guangzhou First People's Hospital,
Henan Provincial People's Hospital,
Luliang University,
Guangzhou Medical University,
Icahn School of Medicine at Mount Sinai
show all 9
ORCID:
0000-0002-3397-4579
Observed ORCID:
0000-0002-3397-4579
OpenAlex ID:
A5100404957
AP-1 Activated by Toll-like Receptors Regulates Expression of IL-23 p19
2009
·
Weicheng Liu
, Xinshou Ouyang
, et al.
·
Journal of Biological Chemistry
·
140
PDF
Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation
2011
·
Xinshou Ouyang
, Ruihua Zhang
, et al.
·
Nature Communications
·
125
PDF
Specific Interaction of Protein Tyrosine Phosphatase-MEG2 with Phosphatidylserine
2003
·
Runxiang Zhao
, Xueqi Fu
, et al.
·
Journal of Biological Chemistry
·
33
PDF
Improved anti-hepatocellular carcinoma effect by enhanced Co-delivery of Tim-3 siRNA and sorafenib via multiple pH triggered drug-eluting nanoparticles
2022
·
Chenghua Song
, Jia Zhang
, et al.
·
Materials Today Bio
·
31
PDF
High levels of Tim-3+Foxp3+Treg cells in the tumor microenvironment is a prognostic indicator of poor survival of diffuse large B cell lymphoma patients
2021
·
Weijie Zhong
, Xiudan Liu
, et al.
·
International Immunopharmacology
·
30
Isolation of a Putative Ribosome Inactivating Protein from Dried Roots ofTrichosanthes kirilowiiUsed in Traditional Chinese Medicine
2004
·
Xu Fei
, Marco Hill
, et al.
·
Planta Medica
·
7
Dataset on preparation of the phosphorylated counterparts of a Momordica charantia protein for studying antifungal activities against susceptible dose-dependent C. albicans to antimycotics
2017
·
Yuanbiao Qiao
, Li Song
, et al.
·
Data in Brief
·
3
PDF
Efficacy and safety of bevacizumab biosimilar SIBP04 compared with bevacizumab (Avastin®) as first-line treatment for locally advanced or metastatic non-squamous non-small-cell lung cancer: A randomized, double-blind, phase 3 trial
2025
·
Yuankai Shi
, Minghong Bi
, et al.
·
Cancer Pathogenesis and Therapy
·
2
Effects of Chemotherapy on Peripheral Blood NK Cell Receptor NKG2D and Related Immune Cytokines in Patients with Non-Small Cell Lung Cancer
2022
·
Jingjing Zhang
, Dianbin Song
, et al.
·
Journal of Cancer Therapy
·
1
PDF
Denosumab biosimilar (LY01011) in the treatment of bone metastases in patients with solid tumors: A multicenter, randomized, double-blind, active comparator-controlled phase 3 study.
2023
·
Mingchuan Zhao
, Xichun Hu
, et al.
·
Journal of Clinical Oncology
Decitabine may effectively treat CMML/MDS-associated inflammatory bowel disease by regulating the Th17/Treg balance
2023
·
Guobiao Luo
, Guanlun Gao
, et al.
·
Research Square
PDF
A multicenter, randomized, double-blind, phase III trial comparing denosumab biosimilar QL1206 and denosumab in patients with bone metastases from solid tumors.
2022
·
Huiping Li
, Yan Huang
, et al.
·
Journal of Clinical Oncology
ヒト骨髄由来間葉系幹細胞はil-6分泌およびil-17aレベルを上昇させることによりびまん性大細胞型b細胞リンパ腫の増殖および薬物耐性を促進する【jst・京大機械翻訳】
2019
·
Weijie Zhong
, Zhu Zhigang
, et al.
化合物W3D通过调控TLR4-MyD88-NF-κB通路抑制LPS诱导的RAW264.7细胞炎症因子的释放
2018
·
罗捷然
, Jie‐ran Luo
, et al.
Th17 cells adoptive immunotherapy impacts tumor growth of diffuse large B-cell lymphoma-bearing mice
2015
·
Xin Xu
, Qingshan Li
, et al.
·
白血病·淋巴瘤
Dynamic observation of GVHD induced by chemotherapy and Th17/Treg in a relapse T-ALL patient after allo-HSCT
2012
·
Chen Zhao
, Qingshan Li
, et al.
·
白血病·淋巴瘤
Determination of total alkaloids in Viscum coloratum by ultraviolet spectrophotometry
2008
·
Qingshan Li
·
Shanxi Yike Daxue xuebao
Show more works
View as search
Works count:
17
Citation count:
372
H-index:
6
I10-index:
5
Year
Topic
Type